2021 U-M Kellogg Eye Center Annual Report

Page 21

Michigan Medicine to Establish Neural Engineering Training Program James Weiland, Ph.D., Professor of Ophthalmology and Visual Sciences and Professor of Biomedical Engineering, led a successful cross-campus effort to establish a Neural Engineering Training Program (NETP) at the University of Michigan. Funding for this new graduate training program will be provided by an institutional research training grant (T32) from the National Institute of Neurological Disorders & Stroke (NINDS). The grant will support advanced training for predoctoral students whose research seeks to advance new applications of technology leading to the development of clinical devices for the treatment of complex neurological disorders.

Kate Kish, doctoral student in Biomedical Engineering, with James Weiland, Ph.D.

From neuromodulation systems that treat epilepsy, movement disorders and pain, to neural prostheses that restore lost

workshop will be conducted in collaboration with the existing

function to eyes and limbs, neurotechnology is transforming

Kellogg Vision Research Training Program.

medicine. “To create the next generation of devices and implants

“Ophthalmology is among the fields with the most to gain

that will truly change lives, we need better human/machine

from supporting the next generation of neural engineering lead-

interfaces, novel new materials, and a fuller realization of the

ers,” says Dr. Weiland, who also directs the U-M BioElectronic

potential of artificial intelligence,” says Dr. Weiland, who will

Vision Lab (BEVL). His lab is at the forefront of creating and

serve as NETP director. “For all of that, we need highly trained

translating technological solutions for visual dysfunction, in-

neural engineers capable of leading interdisciplinary teams to

cluding bioelectronic retinal prostheses and wearable visual aids

keep up with the pace of discovery.”

for the blind.

Kellogg Eye Center is one of eight University of Michigan

The NETP, which launched in July 2021, will initially

entities collaborating to deliver a targeted curriculum, mentor-

support up to four graduate student slots and will sponsor a

ship and student-led initiatives. To ensure that rigorous ana-

number of training and networking opportunities for trainees

lytical techniques are learned and applied, a statistics training

from more than 30 U-M labs.

Endocrine Society Award Terry Smith, M.D., has been awarded the 2022 Gerald D.

Aurbach Award for Outstanding Translational Research from the Endocrine Society. Dr. Smith, the Frederick G.L. Huetwell Professor Emeritus of Ophthalmology and Visual Sciences at Kellogg, and Professor Emeritus of Internal Medicine at the U-M Medical School, is the only endocrinologist in the U.S. with a full-time primary faculty appointment in ophthalmology at an academic eye center. His pioneering work in Graves’ disease and related autoimmune conditions has culminated in the creation of teprotumumab — the first FDA-approved therapy to treat thyroid eye disease. 19


Turn static files into dynamic content formats.

Create a flipbook

Articles inside

Toward a Therapeutic Target for Proliferative Vitreoretinopathy

2min
page 25

State-of-the-Science Microscope Gives Kellogg Researchers New Edge

2min
page 25

Michigan Medicine to Establish Neural Engineering Training Program

2min
page 21

Endocrine Society Award

1min
page 21

Leading on the National Stage

2min
page 15

Marshall Parks Lecture at AAO

1min
page 13

Prioritizing Communication for Patient Safety

2min
page 13

New Faculty Members

3min
page 42

Alumni Highlights

4min
page 39

Recognizing Distinguished Alumni Richard Gutow, M.D., and Gary Gutow, M.D.

6min
pages 36-37

Guarding Photoreceptor Metabolism to Prevent Vision Loss in Inherited Retinal Diseases

2min
page 31

Big Data, Collaboration, and Impact

3min
page 35

A Visionary Legacy

3min
page 33

Eyes on the Future

3min
page 34

Kellogg’s Latest Heed Fellows

3min
page 32

U-M Learners Produce Online Newsletter

3min
page 29

Next-Generation Tools to Treat Abnormal New Ocular Blood Vessels

3min
page 28

Genetically-Modified Occludin Shown to Protect Against Diabetes-Related Vision Loss

2min
page 30

Innovation in Action

3min
page 24

New Pediatric Ophthalmology Fellowship in Ghana

3min
page 27

Kellogg Addresses Technician Shortage with Ongoing Training Program

2min
page 26

Kellogg Researcher Launches First of-its-Kind Study of Health and Aging in Kenya

2min
page 23

A New Regulator of Retinal Angiogenesis Discovered

2min
page 22

Lipid Droplets May Protect Against AMD

2min
page 20

Mapping the Genetic Landscape of Nanophthalmos

2min
page 19

Training Eye Disease Researchers in India

2min
page 18

Kellogg Leads International Team Linking Family’s Symptoms to Rare, Inherited Syndrome

4min
pages 14-15

Clinical Research Update: Patient Perspectives

4min
page 17

Finding New Pathways for the Treatment of Choroideremia

2min
page 16

Finding a Personalized Solution for Dry Eye

3min
page 12

Vitreoretinal Lymphoma: from Symptoms to Diagnosis to Treatment

5min
pages 4-5

In it Together

5min
pages 10-11

Collaborating to Deliver Specialized Care

3min
pages 8-9

Steno North American Fellowship

2min
page 5

The Chair’s Perspective

2min
page 3

Kellogg Offers Multiple Options for Limbal Stem Cell Deficiency

3min
page 7

COVID-19 Transmission Risk in Cornea Transplantation

2min
page 9

NIH-Funded Pilot Program Addresses Disparities in Glaucoma Care

3min
page 6
Issuu converts static files into: digital portfolios, online yearbooks, online catalogs, digital photo albums and more. Sign up and create your flipbook.